Not checkedNot checked for notices yet.
Effectiveness of Allergen-Specific Immunotherapy in Children with Bronchial Asthma
S.M. Nedelskaya, N.M. Marchuk
Zdorovʹe Rebenka · 2013
doi:10.22141/2224-0551.1.44.2013.85186 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
The study of clinical and immunological effectiveness of specific allergen vaccination has been carried out among 487 children with bronchial asthma, depending on the duration of treatment, severity of illness and type of vaccinated allergen. It is found that in all cases specific allergen vaccination has anti-inflammatory and immunocorrective action, the effectiveness of specific allergen vaccination reaches 90.32 % in children with mild bronchial asthma and in 96.94 % of children with moderate severity, and the optimal duration of this treatment which is necessary for the formation of stable remission, is 4–5 years.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.